Vaccine News and Research

Latest Vaccine News and Research

Research: Two out of three at-home ovulation tests do not provide accurate results

Research announced today at the 70th AACC Annual Scientific Meeting & Clinical Lab Expo reveals that two out of three of the digital home ovulation tests sold by U.S. retailers do not accurately predict when a woman is ovulating.

31 Jul 2018

Inhibiting a protein could enhance effectiveness of cancer immunotherapies

Researchers at the Bloomberg~Kimmel Institute for Cancer Immunotherapy in the Johns Hopkins Kimmel Cancer Center discovered inhibiting a previously known protein could reduce tumor burdens and enhance the effectiveness of immunotherapy treatments.

31 Jul 2018

Researchers discover new antibodies that have capacity to treat all Ebola viruses

Researchers at Vanderbilt University Medical Center and their colleagues are a step closer to developing a broadly effective antibody treatment against the three major Ebola viruses that cause lethal disease in humans.

31 Jul 2018

New model for eradicating peste des petits ruminants

Eradicating peste des petits ruminants is an ambitious objective that is neveretheless looking increasingly realistic, notably thanks to a targeted vaccination strategy centring on production systems that act as a virus reservoir.

31 Jul 2018

Scientific group takes new step towards designing new HIV vaccine

The scientific group of Peter the Great St.Petersburg Polytechnic University headed by Professor Andrei Kozlov published the results of a study devoted to the search of solutions for creating the HIV vaccine.

31 Jul 2018

World not ready to deal with a viral pandemic

A team of researchers from the John Hopkins Center for Health Security conducted a simulation with real life implications.

31 Jul 2018

PEACHI project develops vaccine strategies targeting both HIV and hepatitis C virus

An estimated 2.3 million people globally are infected with both human immunodeficiency virus type 1 and hepatitis C virus.

27 Jul 2018

Researchers emphasize need for baby boomers to get tested for hepatitis C

According to the Centers for Disease Control and Prevention, 300 million people across the globe are unaware they're living with viral hepatitis. In fact, baby boomers - those born between 1945-1965 - are five times more likely to have hepatitis C, one of the many different strains of this viral infection.

27 Jul 2018

Research provides new insights about when booster meningitis vaccines are needed

Scientists are indicating that children in Burkina Faso who were vaccinated against group A meningococcal meningitis and septicemia between the ages of 1-4 years in 2010, could need a booster dose of the vaccine as early as this year to ensure they remain protected.

27 Jul 2018

NIH officials highlight growing threat of tickborne diseases

The incidence of tickborne infections in the United States has risen significantly within the past decade. It is imperative, therefore, that public health officials and scientists build a robust understanding of pathogenesis, design improved diagnostics, and develop preventive vaccines, according to a new commentary in the New England Journal of Medicine from leading scientists at the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health

26 Jul 2018

Long-lasting HIV control without antiretroviral therapy is a feasible goal, says expert

Long-lasting control of HIV infection without antiretroviral therapy is a feasible goal that deserves vigorous pursuit, Anthony S. Fauci, M.D., will assert during a lecture on Wednesday, July 25 at the 22nd International AIDS Conference in Amsterdam.

26 Jul 2018

HPV vaccines for boys in UK

The UK government has announced that boys in England aged 12 to 13 years are to be vaccinated against human papillomavirus, or HPV. This injection would protect them against HPV infection. HPV infection has been linked to cervical cancer in women and oral, penile, throat and anal cancer among men.

25 Jul 2018

Newly discovered mechanism may be useful target to stop flu virus from infecting cells

There's a hitch in the swing of a protein that delivers the flu virus. Rice University and Baylor College of Medicine researchers believe this mechanism may be a useful target to stop the virus from infecting cells.

24 Jul 2018

Researchers report first randomized trial results of 'kick and kill' approach to treat HIV

Researchers have reported the results of the first randomized clinical trial to test a novel strategy involving waking up and then killing the 'sleeping' HIV that is hiding in the body using an experimental approach known as 'kick and kill'.

24 Jul 2018

New study provides important clues to developing more effective Ebola vaccines

Scientists conducting the first comprehensive study of key immune system cells - collected from West African Ebola survivors that kill Ebola infected cells have made a surprising discovery that provides important clues to developing effective vaccines against the infection.

24 Jul 2018

Outrage over China vaccines scandal

One of the largest vaccine manufacturers in China, Changchun Changsheng Bio-technology Ltd. was found to have falsified reports in connection with production and inspection of around 113,000 rabies vaccines.

23 Jul 2018

MOF vaccines could increase access to immunization and reduce the risk of global pandemics

Vaccinations are the safest way to protect against disease. However, many vaccines become ineffective when exposed to room temperature or heat.

23 Jul 2018

Studies highlight issues regarding black lung, opioid overdose, police violence and more

This study found the national prevalence of coal worker's pneumoconiosis (black lung) is increasing among working coal miners. In central Appalachia, 20.6 percent of miners working more than 25 years have black lung disease.

20 Jul 2018

AbbVie submits supplemental NDA to FDA for venetoclax to treat acute myeloid leukemia

AbbVie, a research-based global biopharmaceutical company, today announced it submitted a supplemental New Drug Application to the U.S. Food and Drug Administration for venetoclax in combination with a hypomethylating agent or in combination with low-dose cytarabine for the treatment of newly diagnosed patients with acute myeloid leukemia who are ineligible for intensive chemotherapy.

20 Jul 2018

New vaccine could protect unborn babies from Zika virus

Until recently, the Zika virus was not a priority since it affected relatively few people and the cost of creating a vaccine was estimated at EUR 149-468 million. But the spread of Zika in the Americas and discovery of a link with reduced head size and brain damage in babies of women infected while pregnant changed that.

20 Jul 2018

Vaccine News and Research

Latest Vaccine News and Research

Research: Two out of three at-home ovulation tests do not provide accurate results

Inhibiting a protein could enhance effectiveness of cancer immunotherapies

Researchers discover new antibodies that have capacity to treat all Ebola viruses

New model for eradicating peste des petits ruminants

Scientific group takes new step towards designing new HIV vaccine

World not ready to deal with a viral pandemic

PEACHI project develops vaccine strategies targeting both HIV and hepatitis C virus

Researchers emphasize need for baby boomers to get tested for hepatitis C

Research provides new insights about when booster meningitis vaccines are needed

NIH officials highlight growing threat of tickborne diseases

Long-lasting HIV control without antiretroviral therapy is a feasible goal, says expert

HPV vaccines for boys in UK

Newly discovered mechanism may be useful target to stop flu virus from infecting cells

Researchers report first randomized trial results of 'kick and kill' approach to treat HIV

New study provides important clues to developing more effective Ebola vaccines

Outrage over China vaccines scandal

MOF vaccines could increase access to immunization and reduce the risk of global pandemics

Studies highlight issues regarding black lung, opioid overdose, police violence and more

AbbVie submits supplemental NDA to FDA for venetoclax to treat acute myeloid leukemia

New vaccine could protect unborn babies from Zika virus

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Todd Bauman and Chris Povich

Scaling organ‑chip technology for human‑relevant drug discovery

Unlocking drug amorphization: Continuous, solvent-free twin screw granulation

Vaccine News and Research

Latest Vaccine News and Research

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Todd Bauman and Chris Povich

Scaling organ‑chip technology for human‑relevant drug discovery

Unlocking drug amorphization: Continuous, solvent-free twin screw granulation

Newsletters you may be interested in